Today: 4 April 2026
Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI
13 January 2026
1 min read

Pony AI stock slides nearly 10% in New York trade as rate bets reset after CPI

New York, Jan 13, 2026, 14:34 EST — Regular session

  • Pony AI shares dropped roughly 10% in afternoon trading, slipping below $16.
  • Selling hits as investors adjust rate-cut expectations following December CPI data
  • Attention remains on robotaxi expansion efforts and the Fed’s meeting set for Jan. 27-28

Pony AI Inc shares dropped sharply on Tuesday, falling roughly 9.8% to $15.66 in afternoon trading. This slide pulled the autonomous-driving company’s stock well under Monday’s close of $17.37.

The decline was significant since it targeted a high-growth stock sensitive to shifts in risk appetite and interest-rate forecasts. Tuesday’s data revealed U.S. consumer prices climbed 0.3% in December, marking a 2.7% increase from a year ago; core inflation, excluding food and energy, held steady at 2.6% year-over-year. Bureau of Labor Statistics

Traders pushed up expectations for an earlier Federal Reserve rate cut following the inflation report, though the outlook remains uncertain. “A disinflationary trend is gradually taking shape,” noted Seema Shah, chief global strategist at Principal Asset Management. Reuters

Pony’s drop outpaced the wider market. The S&P 500 ETF SPY and Nasdaq 100 ETF QQQ both slipped roughly 0.4%, but the KraneShares CSI China Internet ETF tumbled around 2.2%. Baidu shares also slid about 2.2%.

No immediate comment came from the company on Tuesday’s drop. The latest corporate news focused on expanding its partnership with BAIC BJEV to boost production of Level 4 robotaxis — self-driving cars that operate autonomously in specific zones. Gasgoo Auto News

Under the “Cooperation 2.0” plan, the companies aim to expand beyond a single robotaxi model, rolling out a broader lineup and targeting overseas markets including the Middle East and Europe. This move builds on earlier pilot projects. Gasgoo Auto News

Traders also keep an eye on supply in lightly traded growth stocks. A Form 6-K filed on Jan. 7 revealed December share activity, covering stock options exercised and restricted share units that vested under the company’s equity plans.

Pony AI, listed on two exchanges, set its Hong Kong IPO price at HK$139 per share last November. The company aimed to raise roughly HK$6.71 billion ($864 million), according to a Reuters report from that period. Reuters

The downside is straightforward to outline. Robotaxi deployments demand heavy capital, regulatory approvals drag on across different cities, and competition in autonomous driving stays intense—particularly if markets turn “risk-off” and start hitting smaller, volatile stocks tied to China.

Investors are now turning their attention to the Fed’s Jan. 27-28 meeting. The policy decision comes out on Jan. 28, followed by a press conference that same afternoon.

Stock Market Today

  • HIVE Digital Technologies Ltd. (HIVE.V) Stock Overview and Market Performance
    April 3, 2026, 10:08 PM EDT. HIVE Digital Technologies Ltd. (HIVE.V) closed at CAD 2.69 on April 2, up 1.89%. The company, operating green energy-powered data centers for digital currency mining, has a market cap of CAD 681 million and a beta of 3.37, indicating higher volatility. While its trailing earnings per share stand at -1.07, revenue for Q3 FY26 reached CAD 93.11 million. The stock showed a strong year-to-date return of 24.44%, outperforming the S&P/TSX Composite index's 3.9%. Analysts maintain a 'Buy' rating despite lowering the price target from 6.5 to 4.5 CAD. HIVE's forward price-to-earnings ratio is 32.26, and it remains focused on blockchain infrastructure with roots dating back to 1987 and headquarters in Texas.
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes
Previous Story

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April
Next Story

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Go toTop